Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.8K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semaglutide improves markers of cardiovascular risk in people with HIV.

AIDS (London, England)·2026
Same author

Primary liver cancer in Georgia: Seven years' experience following the launch of the Hepatitis C Elimination Program, 2015-2022.

PloS one·2026
Same author

Pilot study of epigenetic aging and treatment response to semaglutide in the SLIM LIVER study.

npj aging·2026
Same author

Impact of a factor Xa inhibitor (apixaban) on SIV pathogenesis and response to antiretroviral therapy.

JCI insight·2026
Same author

A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Longitudinal T-Cell Phenotypic Dynamics During Sustained Antiretroviral Therapy in People With HIV.

Open forum infectious diseases·2026

Related Experiment Video

Updated: Apr 18, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

3.9K

Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities.

Ivona Pandrea1, Alan Landay, Cara Wilson

  • 1Center for Vaccine Research and Department of Pathology, University of Pittsburgh, 9014 Biomedical Science Tower 3, 3501 Fifth Avenue, Pittsburgh, PA, 15261-9045, USA, pandrea@pitt.edu.

Current HIV/AIDS Reports
|January 22, 2015
PubMed
Summary

Antiretroviral therapy controls HIV, but chronic inflammation causes non-AIDS complications and accelerated aging. Simian immunodeficiency virus infection in nonhuman primates models these conditions to study pathogenesis and interventions.

More Related Videos

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

9.3K
Author Spotlight: Marmoset Research - Scope and Challenges
04:52

Author Spotlight: Marmoset Research - Scope and Challenges

Published on: June 9, 2023

2.9K

Related Experiment Videos

Last Updated: Apr 18, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

3.9K
Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

9.3K
Author Spotlight: Marmoset Research - Scope and Challenges
04:52

Author Spotlight: Marmoset Research - Scope and Challenges

Published on: June 9, 2023

2.9K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Aging Research

Background:

  • Antiretroviral therapy (ART) effectively suppresses HIV replication, shifting the clinical focus from AIDS-defining conditions to non-AIDS complications.
  • These comorbidities, including cardiovascular, kidney, liver disease, neurocognitive disorders, osteopenia, and cancers, are linked to accelerated aging.
  • Chronic inflammation, persisting despite ART, is a key driver of these HIV-associated comorbidities.

Purpose of the Study:

  • To investigate the pathogenesis of non-AIDS comorbidities in the context of persistent HIV-induced inflammation.
  • To utilize a nonhuman primate (NHP) model of Simian Immunodeficiency Virus (SIV) infection to study these complex conditions.
  • To evaluate potential interventions for alleviating non-AIDS-related comorbidities in HIV infection.

Main Methods:

  • Employing progressive SIV infection in NHPs as a model that recapitulates HIV-associated comorbidities.
  • Leveraging the simplified disease course and absence of traditional human risk factors in NHPs for controlled study.
  • Conducting experiments under controlled conditions to characterize disease paradigms and test interventions.

Main Results:

  • SIV infection in NHPs closely mimics the diverse non-AIDS comorbidities observed in humans with HIV.
  • The NHP model allows for the study of comorbidities in the absence of confounding factors like smoking or hyperlipidemia.
  • This model provides a platform for controlled investigation into the mechanisms driving accelerated aging and comorbidities.

Conclusions:

  • Nonhuman primates infected with SIV serve as a valuable model for understanding HIV-related non-AIDS comorbidities and accelerated aging.
  • This model facilitates the characterization of novel AIDS pathogenesis pathways.
  • NHPs offer a robust system for pre-clinical testing of therapeutic interventions targeting HIV comorbidities.